Reduced Breast Cancer Incidents inWomen Treated with Subcutaneous Testosterone.
Channel: BioBalance Healthcast
Date: 2020-08-31

See all the Healthcast at https://www.biobalancehealth.com/healthcast-blog/
There are numerous delivery methods for testosterone replacement for women. These methods include oral, sublingual (under the tongue), vaginal tablets and pills, transdermal cream and gels, but at BioBalance Dr. Maupin only prescribes long acting bio-identical testosterone pellets.   T Pellets are inserted in the fat of the hip, which creates a long lasting, on demand reservoir that provides a woman’s body with a daily dose of testosterone.   Testosterone pellets are replaced every three to four months for women, and are the most effective testosterone replacement available, with the best health profile for anti-aging.  Several studies have confirmed what we have witnessed, that testosterone as pellets reduces the occurrence of initial breast cancer in women. Even more exciting is that T pellets prevent the recurrence of breast cancer.

Dr. Maupin follows the research of Dr. Rebecca Glaser who researches the benefit of testosterone pellets in the health of aging women. Dr Glaser has written many articles about testosterone pellets and breast cancer, and  one of the articles published in the medical journal Maturitas 76, in 2013 focuses on the findings that there are many studies documenting that testosterone for women is protective for the breast and that testosterone therapy treats many symptoms of hormone deficiency in both pre and postmenopausal patients. 

After studying these many studies, Dr Glaser designed a study to focus on the incidence of breast cancer in women treated with testosterone pellets alone without estrogen therapy. The women in the study were divided into two groups, those treated either with testosterone pellets alone or those who were given testosterone pellets combined with anastrozole, a medication that prevents the conversion of testosterone into estrogens.

“The study followed a group of women from 2008 to 2013 and found that Testosterone pellets and or Testosterone/anastrozole pellets delivered subcutaneously in women, reduced the incidence of breast cancer in both pre and postmenopausal women. The evidence supports that belief that breast cancer is preventable by using testosterone pellets which inherently maintain a high Testosterone to estrogen ratio.  The addition of Anastrozole (Arimidex) to the pellet improved the T:E ratio even more than T pellets alone. 

“The women in this study were self- referred or referred by their physicians. They presented with symptoms of relative testosterone deficiency, including hot flashes, sweating, sleep disturbance, heart discomfort, depressive mood, irritability, anxiety, premenstrual syndrome, fatigue, memory loss, menstrual or migraine headaches, vaginal dryness, sexual problems, urinary symptoms including incontinence, musculoskeletal pain and bone loss.”

“The testosterone pellets these women received were composed of non-micronized USP testosterone plus stearic acid or non-micronized USP Testosterone plus stearic acid and USP anastrozole, compressed with 2000 pounds of pressure using a standard sized pellet mold, and pressed into 3.1 mm cylinders.” These pellets are created by a compounding pharmacy. A doctor prescribes them, and they are created and dosed individually for you and delivered to your physician’s office. This is the same process used by Drs.’ Maupin and Sullivan at BioBalance Health.